# The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients

> **NCT06094387** · — · UNKNOWN · sponsor: **Queen Mary Hospital, Hong Kong** · enrollment: 30 (estimated)

## Conditions studied

- Central Line Complication
- Thrombosis, Venous

## Interventions

- **DIAGNOSTIC_TEST:** Thrombin generation assay

## Key facts

- **NCT ID:** NCT06094387
- **Lead sponsor:** Queen Mary Hospital, Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-06
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06094387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06094387, "The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06094387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*